BioGenerator backs 22 startups with $3.5M in 'biggest year ever' of investment

› St. Louis Business Journal

Nicklaus: Promising arthritis drug is a win for St. Louis' biotech strategy

› St. Louis Post-Dispatch

BioGenerator Invests $3.5 Million in 22 St. Louis Bioscience Companies

JPMorgan Chase: Supporting ESO partners, like BioSTL, could be more important than ever

› Equitable Evaluation Practice for Feeding Cities Group

Nicklaus: St. Louis biotech at forefront of preparation for next pandemic

› St. Louis Post-Dispatch

How BioSTL plans to make St. Louis a 'magnet' for pandemic-related technologies

› St. Louis Business Journal

KMOX: BioSTL President Donn Rubin on New Center for Pandemic Resiliency

› KMOX NewsRadio 1120

BioSTL wins $3 million grant for new Pandemic Resiliency center

› St. Louis Post-Dispatch

BioSTL Earns $2.96 Million Federal CARES Act Grant to Launch new Center for Pandemic Resiliency